BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
José María
Bastida Bermejo
Profesor Asociado CC. Salud
Publicaciones en las que colabora con José María Bastida Bermejo (34)
2024
-
Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction
Cellular and Molecular Life Sciences, Vol. 81, Núm. 1
2023
-
Inherited Thrombocytopenia Caused by Variants in Crucial Genes for Glycosylation
International journal of molecular sciences, Vol. 24, Núm. 6
-
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
Blood, Vol. 141, Núm. 4, pp. 406-421
2022
-
A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling
Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1248-1255
-
Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models
Frontiers in Medicine, Vol. 9
-
Low molecular weight heparin is useful in adult COVID-19 inpatients. Experience during the first Spanish wave: observational study
Sao Paulo medical journal = Revista paulista de medicina, Vol. 140, Núm. 1, pp. 123-133
-
Retinal blood vessel calibre and vascular ageing in a general Spanish population: A EVA study
European Journal of Clinical Investigation, Vol. 52, Núm. 2
-
Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis
Medicina Clinica, Vol. 158, Núm. 11, pp. 503-508
2021
-
A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis
American Journal of Hematology
-
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7
-
Characterization of the platelet phenotype caused by a germline RUNX1 Variant in a CRISPR/Cas9-generated murine model
Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1193-1205
2020
-
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Leukemia, Vol. 34, Núm. 6, pp. 1599-1612
-
Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA Study
Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 43-52
-
Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag
Platelets, Vol. 31, Núm. 8, pp. 993-1000
2019
-
Coagulopatías adquiridas
Manual terapéutico (Ediciones Universidad de Salamanca), pp. 402-406
-
Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies
Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824
-
Drug-induced thrombotic microangiopathy during maintenance treatment in a patient with multiple myeloma
HemaSphere, Vol. 3, Núm. 3
-
Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology
International Journal of Laboratory Hematology, Vol. 41, Núm. 1, pp. 109-117
-
Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing
Annals of Medicine, Vol. 51, Núm. 2, pp. 141-148
-
Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders
Seminars in Thrombosis and Hemostasis, Vol. 45, Núm. 7, pp. 695-707